Primary signet-ring cell carcinoma of the bladder treated with laparoscopic radical cystectomy: a case report

Int Cancer Conf J. 2024 Feb 6;13(2):129-133. doi: 10.1007/s13691-023-00648-0. eCollection 2024 Apr.

Abstract

Primary bladder adenocarcinomas comprise 0.5-2% of all epithelial bladder neoplasms. Of these, primary signet-ring cell carcinoma of the bladder is particularly rare, accounting for 0.24% of all bladder malignancies. This tumor is frequently diagnosed at an advanced stage and has a poor prognosis. No standard treatment has yet been established. We here report a patient in whom laparoscopic cystectomy following neoadjuvant chemotherapy was effective. Our patient was a 69-year-old man who had had microscopic hematuria, undergone transurethral resection of a mass in the bladder, and been diagnosed pathologically with a primary signet-ring cell carcinoma of the bladder. No metastases were detected on computed tomography. The patient was treated with a combination of paclitaxel, cisplatin, and gemcitabine prior to undergoing laparoscopic cystectomy. The histopathological diagnosis on this operative specimen was dysplasia and no metastases were detected in the dissected lymph nodes. Complete remission has now been maintained for 9 years.

Keywords: Laparoscopic cystectomy; Neoadjuvant chemotherapy; Paclitaxel; Signet-ring cell carcinoma; Urinary bladder.